bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Khokhar, AR; Li, S; Perez-Soler, R | 1 |
Khokhar, AR; Perez-Soler, R; Siddik, ZH; Wright, K | 1 |
2 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and B16 Melanoma
Article | Year |
---|---|
Improved antitumor activity of cis-Bis-neodecanoato-trans-R,R-1,2- diaminocyclohexaneplatinum (II) entrapped in long-circulating liposomes.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Female; Hyperthermia, Induced; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Tumor Cells, Cultured | 1995 |
Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Hepatic Artery; Infusions, Intra-Arterial; Injections, Intravenous; Liposomes; Liver Neoplasms, Experimental; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Platinum; Rabbits; Tissue Distribution | 1988 |